Healthequity Stock Buy Hold or Sell Recommendation
| HQY Stock | USD 97.41 3.44 3.66% |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding HealthEquity is 'Buy'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell HealthEquity given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for HealthEquity, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out HealthEquity Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide. In addition, we conduct extensive research on individual companies such as HealthEquity and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards HealthEquity. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.
HealthEquity |
Execute HealthEquity Buy or Sell Advice
The HealthEquity recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on HealthEquity. Macroaxis does not own or have any residual interests in HealthEquity or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute HealthEquity's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Buy
Market Performance | Insignificant | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
HealthEquity Trading Alerts and Improvement Suggestions
| HealthEquity has a strong financial position based on the latest SEC filings | |
| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Raymond James Financial Inc. Buys New Holdings in HealthEquity, Inc. |
HealthEquity Returns Distribution Density
The distribution of HealthEquity's historical returns is an attempt to chart the uncertainty of HealthEquity's future price movements. The chart of the probability distribution of HealthEquity daily returns describes the distribution of returns around its average expected value. We use HealthEquity price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of HealthEquity returns is essential to provide solid investment advice for HealthEquity.
| Mean Return | -0.02 | Value At Risk | -2.85 | Potential Upside | 2.58 | Standard Deviation | 1.95 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of HealthEquity historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
HealthEquity Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as HealthEquity, soars without any apparent reason? This usually happens because many institutional investors are aggressively trading HealthEquity back and forth among themselves.
| Shares | Dimensional Fund Advisors, Inc. | 2024-12-31 | 1.6 M | Millennium Management Llc | 2024-12-31 | 1.5 M | Franklin Resources Inc | 2024-12-31 | 1.4 M | Northern Trust Corp | 2024-12-31 | 1.2 M | Goldman Sachs Group Inc | 2024-12-31 | 1.1 M | Loomis, Sayles & Company Lp | 2024-12-31 | 1.1 M | Charles Schwab Investment Management Inc | 2024-12-31 | 1.1 M | Jpmorgan Chase & Co | 2024-12-31 | 1.1 M | Stephens Inv Mgmt Group Llc | 2024-12-31 | 1.1 M | Wealthfront Advisers Llc | 2024-12-31 | 107.4 M | Blackrock Inc | 2024-12-31 | 11 M |
HealthEquity Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (2.3M) | (4.1M) | (30.4M) | 1.0 | 0.9 | 0.95 | |
| Change In Cash | 137.1M | (103.4M) | 28.9M | 149.7M | 172.2M | 180.8M | |
| Free Cash Flow | 84.7M | 3.9M | 31.5M | 196.8M | 226.3M | 237.6M | |
| Depreciation | 115.9M | 137.2M | 161.2M | 153.1M | 176.0M | 184.8M | |
| Other Non Cash Items | 6.9M | 17.2M | 3.5M | 4.0M | 4.6M | 4.8M | |
| Capital Expenditures | 97.0M | 137.1M | 119.1M | 46.1M | 53.0M | 52.1M | |
| Net Income | 8.8M | (44.3M) | (26.1M) | 55.7M | 50.1M | 52.6M | |
| End Period Cash Flow | 328.8M | 225.4M | 254.3M | 404.0M | 464.6M | 487.8M | |
| Change To Netincome | 20.4M | 39.5M | 42.0M | 45.7M | 52.6M | 55.2M | |
| Investments | (97.0M) | 2.4M | (119.1M) | (46.1M) | (41.5M) | (43.5M) | |
| Net Borrowings | 1.2B | (239.1M) | (53.1M) | (8.8M) | (7.9M) | (7.5M) |
HealthEquity Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to HealthEquity or Health Care Providers & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that HealthEquity's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a HealthEquity stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.08 | |
β | Beta against Dow Jones | 1.09 | |
σ | Overall volatility | 1.82 | |
Ir | Information ratio | 0.04 |
HealthEquity Volatility Alert
HealthEquity exhibits very low volatility with skewness of -0.82 and kurtosis of 1.12. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure HealthEquity's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact HealthEquity's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.HealthEquity Fundamentals Vs Peers
Comparing HealthEquity's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze HealthEquity's direct or indirect competition across all of the common fundamentals between HealthEquity and the related equities. This way, we can detect undervalued stocks with similar characteristics as HealthEquity or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of HealthEquity's fundamental indicators could also be used in its relative valuation, which is a method of valuing HealthEquity by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare HealthEquity to competition |
| Fundamentals | HealthEquity | Peer Average |
| Return On Equity | 0.047 | -0.31 |
| Return On Asset | 0.0379 | -0.14 |
| Profit Margin | 0.08 % | (1.27) % |
| Operating Margin | 0.18 % | (5.51) % |
| Current Valuation | 9.25 B | 16.62 B |
| Shares Outstanding | 86.66 M | 571.82 M |
| Shares Owned By Insiders | 2.13 % | 10.09 % |
| Shares Owned By Institutions | 97.87 % | 39.21 % |
| Number Of Shares Shorted | 4.36 M | 4.71 M |
| Price To Earning | 525.29 X | 28.72 X |
| Price To Book | 3.97 X | 9.51 X |
| Price To Sales | 7.34 X | 11.42 X |
| Revenue | 999.59 M | 9.43 B |
| Gross Profit | 751.54 M | 27.38 B |
| EBITDA | 282.42 M | 3.9 B |
| Net Income | 55.71 M | 570.98 M |
| Cash And Equivalents | 176.89 M | 2.7 B |
| Cash Per Share | 2.09 X | 5.01 X |
| Total Debt | 933.14 M | 5.32 B |
| Debt To Equity | 0.54 % | 48.70 % |
| Current Ratio | 2.46 X | 2.16 X |
| Book Value Per Share | 24.47 X | 1.93 K |
| Cash Flow From Operations | 242.83 M | 971.22 M |
| Short Ratio | 6.08 X | 4.00 X |
| Earnings Per Share | 1.09 X | 3.12 X |
| Price To Earnings To Growth | 1.07 X | 4.89 X |
| Target Price | 116.79 | |
| Number Of Employees | 3.13 K | 18.84 K |
| Beta | 0.62 | -0.15 |
| Market Capitalization | 8.44 B | 19.03 B |
| Total Asset | 3.16 B | 29.47 B |
| Retained Earnings | 205.63 M | 9.33 B |
| Working Capital | 440.35 M | 1.48 B |
Note: Acquisition by Parker Stuart B. of 771 shares of HealthEquity subject to Rule 16b-3 [view details]
HealthEquity Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as HealthEquity . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About HealthEquity Buy or Sell Advice
When is the right time to buy or sell HealthEquity? Buying financial instruments such as HealthEquity Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having HealthEquity in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Warren Buffett Holdings Thematic Idea Now
Warren Buffett Holdings
A long-term portfolio of publicly-traded stocks on US exchanges that are owned by Warren Buffett's holding company Berkshire Hathaway. The Warren Buffett Holdings theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Warren Buffett Holdings Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for HealthEquity Stock Analysis
When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.